The news: HumanFirst (formerly Elektra Labs), a tech startup focused on building out remote clinical trials, and the Duke Clinical Research Institute (DCRI) are launching the Digital Measures Evaluation Center to assess how biometric sensors and other digital health measures can be best used in clinical trials.
Why it’s worth watching: More drugmakers and hospitals have turned to remote, digital clinical trials since the onset of the pandemic, and it’s catalyzing the proliferation of remote patient monitoring (RPM) tech.
The challenge: One major hurdle to scaling remote trials is determining whether RPM devices stack up to in-person medical-grade health tracking.
For pharma cos to reap the full benefits of decentralized clinical trials, the data collection and analysis need to be sound. For example, even though the Apple Watch heart rate function claims to be accurate for detecting atrial fibrillation, it only applies to one-third of cases.
The opportunity: Efforts made by the new Digital Measures Evaluation Center could help further legitimize the use of RPM devices in clinical trials and speed up pharma cos’ decentralized clinical trials efforts.